Triglyceride accumulation in injured renal tubular cells: Alterations in both synthetic and catabolic pathways  by Johnson, A.L.I.C.M. et al.
Kidney International, Vol. 67 (2005), pp. 2196–2209
Triglyceride accumulation in injured renal tubular cells:
Alterations in both synthetic and catabolic pathways
ALI C.M. JOHNSON, ANDREAS STAHL, and RICHARD A. ZAGER
Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Biochemistry, Stanford University, Palo, Alto,
California; and Department of Medicine, University of Washington, Seattle, Washington
Triglyceride accumulation in injured renal tubular cells: Alter-
ations in synthetic and catabolic pathways.
Background. Triglycerides can accumulate in injured tissues,
a process thought to represent flux of excess, cytotoxic, free
fatty acids into nontoxic triglyceride storage pools. However,
this view may be overly simplistic, given that multiple pathways
may impact triglyceride levels. This study sought new insights
into this issue.
Methods. Cultured human proximal tubule [human kidney-
2 (HK-2)] cells or in vivo kidney were subjected to injuries
known to increase triglyceride levels ∼three- to fourfold [HK-
2 cells antimycin A–induced mitochondrial blockade; in vivo
glycerol-induced rhabdomyolysis; endotoxemia). Six reverse
transcription-polymerase chain reactions (RT-PCRs) were used
to monitor mouse/human mRNAs for renal fatty acid trans-
port protein (FATP2), or triglyceride-synthesizing enzymes
(acyl-coenzyme A:diacylglycerol acyltransferases DGAT1 and
DGAT2). Fatty acid synthase (FAS) and FATP2 were gauged
by Western blot. FAS, FATP2, mitochondrial respiration, and
phospholipase A2 (PLA2) effects on cell triglyceride accumu-
lation were probed. Finally, tissue lipase activity was assessed.
Results. Antimycin A up-regulated multiple determinants
of HK-2 cell triglyceride formation, including FATP2, FAS,
DGAT1, and DGAT2 (proteins and/or mRNAs). However,
neither FAS- nor FATP2-inhibition eliminated antimycin
A–induced triglyceride loading, indicating the latter’s multi-
factorial basis. PLA2 activity increased FFA and triglyceride
content. Rhabdomyolysis and endotoxemia altered multiple
triglyceride homeostatic mechanisms. However, these changes
were model-dependent and did not closely parallel those in
HK-2 cells. Lipase activity signficantly fell (glycerol) or rose
(endotoxemia) with different forms of tissue damage.
Conclusion. Injury-induced triglyceride accumulation stems
from multiple, and disease-specific, changes in triglyceride syn-
thetic and degradative pathways. Simple flux of excess FFAs
into triglyceride pools is an overly simplistic view of the post-
injury-triglyceride loading state.
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Triglycerides are the body’s dominant energy stor-
age form, serving as a depot for, and a source of, free
fatty acids (FFAs) for mitochondrial beta oxidation, and
hence, adenosine triphosphate (ATP) production [1–3].
In addition, triglyceride formation is thought to represent
a cellular cytoprotective response, mitigating so-called
“lipotoxicity” (e.g., [4–6]). According to this concept,
as injured tissues accumulate excess FFAs from accel-
erated phospholipase A2 (PLA2)–induced phospholipid
catabolism, cytotoxicity can result. The latter may arise
via a number of mechanisms, including FFA-mediated
mitochondrial injury, cytochrome c release [4–6], and
direct plasma membrane toxicity or lysis [7–9]. There-
fore, shuttling of elevated FFA burdens into triglyceride
pools may serve a homeostatic function, staving off FFA-
mediated injury, apoptosis, or necrotic cell death [1–3].
Triglycerides are primarily synthesized in liver, intes-
tine, and adipocytes [1]. However, that acyl-coenzyme
A:diacylglycerol acyltransferases (DGATs), the enzymes
which catalyze the final step of triglyceride synthesis, are
expressed in most tissues [10], including kidney [11], sug-
gest the potential broad based relevance of this cytopro-
tective pathway.
In 1983, Tannenbaum, Purkerson, and Klahr [12] re-
ported that ureteral obstruction causes triglycerides to
accumulate in renal cortex and medulla. This study
was the first to indicate that renal injury can alter
triglyceride metabolism. However, it was not determined
whether triglyceride accumulation was unique to obstruc-
tive nephropathy [12]. Therefore, this laboratory recently
undertook a series of experiments [13] in which triglyc-
eride levels were measured in renal cortex following
diverse forms of in vivo renal injury [myoglobinuria,
endotoxemia, ischemia/reperfusion (I/R)], and in cell
culture experiments [mitochondrial blockade of human
kidney-2 (HK-2) cells with antimycin A]. In all instances,
three- to fourfold triglyceride increases were observed
[13]. The potential pathogenic relevance of this process
was suggested by the fact that when proximal tubule
(HK-2) cell triglyceride loading was induced by providing
excess triglyceride substrate (FFA), altered tubular cell
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Fig. 1. Schematic of fatty acid homeostasis with triglyceride (TG) in-
corporation. Free fatty acid (FFA) levels can be supported by (1) in
situ synthesis via the action of fatty acid (FA) synthase; (2) intracel-
lular transport via fatty acid transport protein 2 (FATP2), the domi-
nant renal fatty acid transport protein; or (3) injury-induced activation
of phospholipase A2 (PLA2) with subsequent deacylation of cellular
phospholipids (PL). (4) The fatty acids undergo mitochondrial oxida-
tion for adenosine triphosphate (ATP) synthesis. A blockade in mito-
chondrial respiration, or a reduction in tubular energy demand [e.g., a
decrease in glomerular filtration rate (GFR) with a subsequent decrease
in tubular sodium reabsorption/ATP consumption], would be expected
to decrease mitochondrial fatty acid consumption, and hence, augment
the intracellular FFA pool. (5) FFA activation via an ATP-dependent
process (forming acyl-coenzyme A) is required for their incorporation
into triglycerides. Thus, with severe ATP depletion, a failure of FFA
utilization for triglyceride synthesis may result. (6) An increase in ac-
tivated FFAs would be expected to augment triglyceride formation via
DGAT activity. (7) Triglyceride concentrations reflect the balance be-
tween triglyceride synthesis and degradation, the latter mediated via
lipase activity. Not depicted, potential triglyceride import or export
could further alter cellular triglyceride pools. DGAT is the enzyme
acyl-coenzyme A:diacylglycerol acyltransferase.
susceptibility to superimposed ATP depletion, or iron-
mediated oxidant injury resulted [13].
Cellular triglyceride levels presumably reflect a com-
plex interplay between substrate (most notably FFA)
availability, DGAT-mediated triglyceride assembly, and
triglyceride catabolism [14–16]. Given these heteroge-
neous and interactive pathways (schematically depicted
in Figure 1 and discussed in its legend), the concept
that triglyceride accumulation represents a flux of ex-
cess FFAs into triglyceride pools may be overly simplis-
tic. Therefore, the present study was undertaken to gain
potential new insights into this issue. Toward this end,
extensive studies have been performed in a cell culture
model of proximal tubular cell injury. Correlations were
then sought with far more complex models of in vivo acute
renal failure (ARF) previously noted to evoke a triglyc-
eride loading state [13]. The results of these experiments
form the basis of this report.
METHODS
Cultured human proximal tubule (HK-2)
cell experiments
General procedures for cell culture experiments. HK-
2 cells, an immortalized proximal tubule cell line de-
rived from normal human kidney [17], were used for all
in vitro experiments. The cells were maintained in ker-
atinocyte serum-free medium (K-SFM), to which was
added 2 mmol/L glutamine, 5 ng/mL epidermal growth
factor (EGF), 40 lg/mL bovine pituitary extract, 25 U/mL
penicillin, and 25 lg/mL streptomycin, as previously de-
scribed [17]. All experiments were conducted at near con-
fluence, with cells growing in T75 Costar flasks (Costar,
Cambridge, MA, USA). Following specific experiments,
as delineated below, cell injury was assessed by% lactate
dehydrogenase (LDH) release [8]. Cells were detached
from the flasks with a rubber policeman, pelleted by cen-
trifugation, washed ×3 with Hank’s balanced salt solution
(+ Ca2+/Mg2+) and extracted for either (1) lipid (in chlo-
roform:methanol) [13]; (2) total RNA (TRIzol method)
[18]; or (3) protein [18, 19], depending on the specific ex-
periment (see below). Triglyceride values were expressed
as nmol/lmol of recovered phospholipid phosphate (Pi)
assayed as described elsewhere [20]. RNA samples were
used for reverse transcription-polymerase chain reaction
(RT-PCR) quantitation of selected mRNA expression
[DGAT1, DGAT2, or renal fatty acid transport protein
2 (FATP2) mRNAs, each factored by glyceraldehyde-
3-phophate dehydrogenase (GAPDH) signal]. Protein
samples were used for Western blot analyses [for FATP2
or fatty acid synthase (FAS); specifics presented below].
Specific HK-2 cell experiments
Antimycin A-mediated triglyceride accumulation: Im-
pact of de novo fatty acid synthesis. This experiment was
undertaken to ascertain whether increased fatty acid syn-
thesis is responsible for triglyceride accumulation in re-
sponse to mitochondrial blockade. T75 flasks of HK-2
cells (N = 16) were divided into four groups (four flasks
each) as follows: (1) control incubation; (2) incubation
with a FAS inhibitor (cerulenin) [21, 22] (Calbiochem,
Santa Cruz, CA, USA) in 0.04% dimethyl sulfoxide
(DMSO); (3) antimycin A (7.5 lmol/L in 0.1% ethanol);
or (4) antimycin A + cerulenin. After an 18-hour incuba-
tion,% LDH release was determined, and then the cells
were subjected to lipid extraction and triglyceride analy-
sis, using an enzymatic assay (#2780-400H) (Thermo Elec-
tron, Arlington, TX, USA) [13].
Antimycin A: Effects on FAS expression. To com-
plement the above studies, the impact of antimycin A–
mediated mitochondrial blockade on FAS expression was
assessed [23, 24]. Eight T75 flasks of HK-2 cells were in-
cubated either with 7.5 lmol/L antimycin A or with its
vehicle (0.1% ethanol). After an 18-hour incubation, the
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cells were recovered and protein extracts were probed
for FAS by Western blotting (described below).
Antimycin A effects on HK-2 cell FATP2 (protein) ex-
pression. The following experiment were undertaken
to ascertain whether antimycin A causes an increase in
the dominant renal tubular plasma membrane fatty acid
transport protein, FATP2 [25, 26]. Eighteen flasks of HK-
2 cells were incubated for 18 hours either with 7.5 lmol/L
antimycin A (N = 9) or its vehicle (N = 9). The cells were
then recovered, protein extracts prepared, and probed for
FATP2 (see below).
Antimycin A effects on FATP2 mRNA. Because the
above experiment indicated that antimycin A increased
FATP2 protein levels (see Results section), this exper-
iment ascertained whether that change could be tran-
scriptionally regulated. Sixteen flasks of HK-2 cells were
divided into four experimental groups (four flasks each):
(1) control incubation × 4 hours; (2) control incubation ×
18 hours; (3) 7.5 lmol/L antimycin A treatment × 4 hours;
and (4) antimycin A treatment × 18 hours. All control
incubations were conducted with the antimycinA vehi-
cle (0.1% ethanol). After the incubations, the cells were
recovered, the RNA extracted and reverse transcribed
(RT), as previously described [18]. FATP2 and GAPDH
mRNAs were assessed by multiplexing RT-PCR. The
specific methodologies and conditions employed are de-
scribed below.
DGAT1 and DGAT2 mRNA expression: Effects of an-
timycin A. To gauge potential effects of antimycin A
on DGAT expression, the mRNAs for both DGAT1 and
DGAT2 were assessed by RT-PCR, using the same HK-2
cell samples which were probed for FATP2 mRNA (see
above). Of note, anti-DGAT antibodies were not avail-
able for Western blotting. Hence, these experiments were
necessarily restricted to mRNA analyses. The conditions
and primers used for DGAT analyses are described be-
low.
PLA2 effects of HK-2 triglyceride levels. It was previ-
ously demonstrated that antimycin A treatment of cul-
tured tubular cells causes PLA2 induced phospholipid
hydrolysis [27]. The following experiment was designed
to directly test whether the resulting FFA release results
in triglyceride formation. Nine T75 flasks of HK-2 cells
were incubated for 3 hours either under control culture
conditions (N = 3), or with the addition of bovine pan-
creatic PLA2 (P8913) (Sigma Chemical Co., St. Louis,
MO, USA) (5 or 20 U/mL) [28] (N = 3 flasks with each
treatment). The cells then underwent lipid extraction and
triglyceride enzymatic analysis, as above.
Isolated mouse proximal tubule segment experiments
ARF reduces mitochondrial respiration [decreased
sodium reabsorption due to decreased glomerular filtra-
tion rate (GFR) and mitochondrial damage/blockade]
[29–31]. Therefore, the following experiment was under-
taken to ascertain the impact of decreased mitochon-
drial respiration/blockade on both FFA availability and
possible triglyceride formation. To address this issue, ex-
periments were undertaken using freshly isolated mouse
proximal tubular segments [32] because they are com-
pletely dependent on mitochondrial respiration to sustain
ATP levels (unlike HK-2 cells, which can sustain near nor-
mal ATP by either aerobic or anaerobic metabolism [33]).
Mouse proximal tubules were isolated from two mice as
routinely performed in this laboratory [32]. Each prepa-
ration was suspended in standard incubation medium
[32] and divided into four equal aliquots, as follows: (1)
control incubation (95% O2/5% CO2); (2) 5 U/mL of
exogenous PLA2 (as above); (3) 100 lmol/L antimycin
A; or (4) combined antimycin A + PLA2 treatment. To
block antimycin A–induced lethal cell injury, 2 mmol/L
glycine was added to each aliquot [34]. After completing
30-minute incubations, lipid extracts were prepared and
assayed for FFA [35] and triglyceride content [13]. Values
were expressed per mg protein in each tubule aliquot.
In vivo mouse experiments: Glycerol-induced ARF
The following experiments were undertaken to ascer-
tain potential mechanisms by which the glycerol model
of ARF induces renal cortical triglyceride loading [13].
Male CD-1 mice (25 to 35 g) (Charles River Labora-
tories, Wilmington, MA, USA), maintained under nor-
mal vivarium conditions, were used for all experiments.
On the day of experimentation, the mice were briefly
anesthetized with isoflurane and injected with 50% glyc-
erol (total dose of 8.5 mL/kg body weight; adminis-
tered in equally divided doses into muscle in each hind
limb). The mice were allowed to recover from anesthe-
sia, returned to their cages, and provided free food and
water access. Eighteen hours later, they were deeply anes-
thetized with pentobarbital (2 to 4 mg), and the abdom-
inal cavities were opened. One kidney per mouse was
resected and saved for subsequent protein, lipid, or RNA
extraction, as detailed below. A terminal blood sample
was obtained from the inferior vena cava for blood urea
nitrogen (BUN) analysis to gauge the severity of ARF.
Specific experiments are detailed below:
FATP2: Western blot and mRNA analyses. Seven mice
were subjected to the above glycerol model of ARF.
Seven sham-injected mice served as controls. Eighteen
hours later, a plasma sample was obtained from each
mouse for BUN analysis, the kidneys were resected, iced,
and the cortices were dissected with a razor blade. The
tissues obtained from one kidney per mouse underwent
protein extraction for subsequent Western blotting (see
below). The cortical tissue from the second kidney was
used for RNA extraction for subsequent FATP2 mRNA
analysis by RT-PCR (described below).
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DGAT1 and DGAT2 mRNA assessments. The above
RNA samples, gathered to assess FATP2 mRNA, were
also probed for DGAT1 and DGAT2 mRNAs by RT-
PCR (see below).
FAS Western blotting. FAS protein expression in kid-
ney at 18 hours post-glycerol treatment was assessed. To
this end, four renal cortical protein extracts, obtained 18
hours post-glycerol injection, and four control renal cor-
tical protein extracts, were probed for FAS by Western
blot (see below).
In vivo mouse experiments: Endotoxemic ARF
FATP2: Western blot and mRNA analyses. Twenty
mice, maintained under routine vivarium conditions with
free food and water access, were individually placed in
cylindric restrainers and subjected to tail vein injections
of 10 mg/kg of purified endotoxin [lipopolysaccharide
(LPS) from Escherichia coli 0111:B4] (#L-2630) (Sigma
Chemical Co.) [13], in 0.1 mL saline. An equal number of
control mice received an equal volume of saline contain-
ing no LPS. The mice were then returned to their cages.
Approximately 18 hours later, the mice were deeply anes-
thetized with pentobarbital, the abdominal cavities were
opened through a midline abdominal incision, and a hep-
arinized blood sample was obtained from the inferior
vena cava for BUN analysis. The kidneys were then re-
moved. One was used to prepare a protein extract for
subsequent Western blotting for FATP2 (see below). The
other was used to extract total RNA for FATP2 mRNA
analysis (described below).
DGAT1 and DGAT2 mRNA assessments. Samples
of RNA, gathered to assess FATP2 mRNA, were also
probed for DGAT1 and DGAT2 mRNAs by RT-PCR
(N = 6 samples from both control mice and from 18 hours
post-LPS–injected mice). The details of those analyses
are described below.
FAS Western blotting. Protein samples obtained from
five control kidneys and six post-LPS kidneys were
probed for FAS. These were analyzed as noted for the
post-glycerol samples (see below).
Western blotting methodologies
Renal cortical tissue samples were extracted for pro-
tein [36] and probed for either FATP2 or FAS by
Western blotting using previously described method-
ologies [18, 36]. In brief, 10 lg of protein extract (for
FATP2) or 150 lg of protein extract (for FAS) were elec-
trophoresed through a 4% to 12% gradient Bis-Tris acry-
lamide Criterion XT gel (Bio-Rad, Hercules, CA, USA).
Proteins were transferred to nitrocellulose membranes
using a Hoefer SemiPhor Semi-Dry Transfer apparatus
(Amersham-Pharmacia, Piscataway, NJ, USA), accord-
ing to the manufacturer’s instructions. To optimize the
transfer of the larger FAS protein (265 kD), conditions
were slightly altered, decreasing the addition of methanol
to the Tris/glycine buffer (to 10%) and increasing transfer
time (2 hours). Membranes were probed for FATP2 with
rabbit anti-FATP2 primary antibody at a 1:1500 dilution.
The employed rabbit FATP2 antibody preparation was
raised (by Andreas Stahl) against the last 26 amino acids
of murine FATP2 (MDDAEKTFVPMTENIYNAIIDK-
TLKL) fused to glutathione-S-transferase (GST) (this
antiserum recognized in Western blots a single band of 70
kD solely from kidney and liver lysates, in agreement with
the expected tissue distribution and molecular weight of
mouse FATP2). FAS was probed with mouse anti-FAS
primary antibody (#610963) (BD Transduction Labora-
tories, San Diego, CA, USA), according to the manufac-
turer’s instructions. Anti-FATP2 and anti-FAS primary
antibodies were identified using horseradish peroxidase–
labeled donkey antirabbit IgG (#NA-934) (Amersham-
Pharmacia), and horseradish peroxidase–labeled sheep
antimouse IgG (#NA931) (Amersham-Pharmacia), re-
spectively. Proteins were visualized by enhanced chemilu-
minescence (ECL Kit) (Amersham-Pharmacia). The rel-
evant protein bands (FATP2, 70 kD and FAS, 265 kD)
were semiquantified by densitometry.
HK-2 cells were extracted for proteins and the lat-
ter subjected to Western blotting as previously described
[18]. FATP2 and FAS detection were performed as noted
above (10 lg and 35 lg protein were electrophoresed,
respectively).
Nonspecific secondary antibody staining in the above
experiments was excluded by the fact that the secondary
antibody, in the absence of the primary antibody, did not
identify the relevant protein bands. Equal protein load-
ing/transfer was verified by India ink staining. Blot semi-
quantitative analysis was performed by band densitome-
try.
Analyses of DGAT1, DGAT2, and FATP2 mRNA
by RT-PCR
Mouse. RT-PCR was employed to measure DGAT1,
DGAT2, and FATP2 mRNAs in total RNA isolated from
mouse renal cortex. Renal cortical tissues, obtained as
discussed above, were immediately placed into TRIzol
reagent (Invitrogen Life Technologies, Carlsbad, CA,
USA). Total RNA was extracted according to the manu-
facturer’s instructions. The final RNA pellet was brought
up in RNase-free water to an approximate concentration
of 1 to 2 mg/mL.
HK-2 cells. To measure the human homologues of
DGAT1, DGAT2, and to assess FATP2 mRNA, total
RNA from HK-2 cells was extracted as previously de-
scribed using TRIzol reagent [18]. The final RNA pellet
was brought up in RNase-free water to an approximate
concentration of 1 mg/mL.
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Table 1. Primers and conditions used for reverse transcription-polymerase chain reaction (RT-PCR) assessments of mouse acyl-coenzyme
A:diacylglycerol acyltransferases DGAT1, DGAT2, fatty acid transport membrane 2 (FATP2), and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNAs
Genes Primer sequences PCR conditions Product size
Mouse 5′-CTG TGC TCA TGT ATG TCC ACG ACT-3′ 94◦C, 60 sec; 58.5◦C, 60 sec; 223 bp
DGAT1 5′-CTG GCT CAT ACC AGT GCT GAG ATT-3′ 72◦C, 60 sec; 28 cycles
Mouse 5′-GCA AGA AGT TTC CTG GCA TAA GGC-3′ 94◦C, 60 sec; 58.5◦C, 60 sec; 833 bp
DGAT2 5′-GCA GGA CAC ACT AGA AGT GAG CTT-3′ 72◦C, 60 sec; 24 cycles
Mouse 5′-AGT TCT ACG CAT CCA CTG AAG GCA-3′ 94◦C, 60 sec, 58.5◦C, 60 sec; 650 bp
FATP2 5′-TGA CTG TGG GAT TGA AGC CCT CTT –3′ 72◦C, 60 sec; 24 cycles
Mouse 5′-CTG CCA TTT GCA GTG GCA AAG TGG-3′ 94◦C, 60 sec, 58.5◦C, 60 sec; 437 bp
GAPDH 5′-TTG TCA TGG ATG ACC TTG GCC AGG-3′ 72◦C, 60 sec; 18-24 cycles
Results, presented in the accompanied figures, are presented as DGAT or FATP2 signals divided by GAPDH signal, as described in text.
Table 2. Primers and conditions used for reverse transcription-polymerase chain reaction (RT-PCR) assessments of human acyl-coenzyme
A:diacylglycerol acyltransferases DGAT1, DGAT2, fatty acid transport protein 2 (FATP2) and glyceraldehyde-3-phosphate dehydogenase
(GAPDH) mRNAs
Genes Primer sequences PCR conditions Product size
Human DGAT1 5′-TGC CCG GTT ATT TCT GGA GAA CCT-3′ 94◦C, 60 sec; 59◦C, 60 sec; 573 bp
homologue 5′-AGC TGG GTG AAG AAC AGA ATC TCA-3′ 72◦C, 60 sec; 26 cycles
Human DGAT2 5′-TGC TCT ACT TCA CTT GGC TGG TGT-3′ 94◦C, 60 sec; 59◦C, 60 sec; 701 bp
homologue 5′-ACC AGT GGT GAT GGG CTT GGA GTA-3′ 72◦C, 60 sec; 26 cycles
Human 5′-TGC TAC TCT TGC CTT GCG GAC TAA -3′ 94◦C, 60 sec; 58◦C, 60 sec; 261 bp
FATP2 5′-CCA ATA TTG CCT TCA GTG GCA GCA-3′ 72◦C, 60 sec; 30 cycles
Human 5′-GTC TTC ACC ACC ATG GAG AAG-3′ 94◦C, 60 sec, 58-59◦C, 60 sec; 490 bp
GAPDH 5′-GCT TCA CCA CCT TCT TGA TGT CAT C-3′ 72◦C, 60 sec; 19-25 cycles
Results, presented in the accompanied figures, are presented as DGAT or FATP2 signals divided by GAPDH signal, as described in text.
RT-PCR. RT and PCR were performed using the
First-Strand Synthesis Kit for RT-PCR (Ambion Inc.,
Austin, TX, USA) as previously described in detail [19].
The specific primers for mouse and human DGAT1,
DGAT2, and FATP2 were designed with 50% to 60%
guanine and cytosine (GC) composition (see Tables 1
and 2). The human homologue DGAT1 and DGAT2 se-
quence products were verified using the Big Dye Termi-
nator Kit (PE-Biosystems, Foster City, CA, USA). The
similarity in annealing temperature, but dissimilarity in
PCR product sizes, enabled a multiplexing reaction with
each set of primers for a given mouse or human mes-
sage, and the corresponding mouse or human GAPDH
(used as a reference housekeeping gene). Each primer
set was optimized for a given determination by vary-
ing the cycle at which the GAPDH primers were added
(mouse GAPDH cycles DGAT1, 18; DGAT2, 19; and
FATP2, 24; human GAPDH cycles DGAT1 and DGAT2,
19 and FATP2; 25). PCR products were analyzed by
agarose gel electrophoresis and ethidium bromide stain-
ing. cDNA bands were visualized and quantified by
densitometry using a Typhoon 8600 scanner (Amersham-
Pharmacia). DGAT1, DGAT2, and FATP2 cDNA bands
were expressed as a ratio to the simultaneously obtained
GAPDH cDNA bands.
Tissue lipase assay. The following experiments were
undertaken to assess whether renal tubular lipase activ-
ity is altered in the aftermath of different forms of in-
jury, potentially impacting triglyceride levels by altering
triglyceride hydrolysis. To this end, the following mod-
els were employed: (1) the glycerol model of ARF in
which the renal cortical samples were obtained from 18
mice: nine mice injected with glycerol 18 hours previ-
ously and nine control mice; (2) the endotoxemic model
of ARF in which tissues were collected from 8 mice 18
hours post-tail vein LPS injection, and from eight con-
trol mice (18 hours post-sham tail vein LPS injection);
and (3) I/R injury in which preliminary data indicated
that insufficient lipase activity existed in HK-2 cells to al-
low for accurate assessments using the developed assay
(see below); thus, an additional in vivo model of renal
injury (I/R) which evokes triglyceride loading [13] was
used. Three mice were deeply anesthetized with pento-
barbital, a midline laparotomy was performed, the left
renal pedicle was identified, and then occluded with a
smooth vascular clamp × 15 minutes. Body temperature
was maintained at 36 to 37◦C with an external heating
source. Following vascular clamp removal, the abdomi-
nal incisions were sutured and the animals were returned
to their cages with free food and water access. Eighteen
hours later, the mice were reanesthetized and the post-
ischemic left kidneys and the contralateral (control) right
kidneys were resected.
Tissue lipase analysis. Renal cortical tissues were dis-
sected and immediately placed into an iced glass dounce
homogenizer containing 400 lL potassium phosphate
buffer (0.1 mol/L, pH 7.2) with a protease inhibitor
cocktail (1 697 498; Roche Diagnostics, Mannheim,
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Fig. 2. Fatty acid synthase (FAS): Role in an-
timycin A (AA)-induced triglyceride (TG)
accumulation in human kidney 2 (HK-2)
cells. Left panel, HK-2 cells were main-
tained either under control (C) condi-
tions ± cerulenin; or incubated with an-
timycin A ± cerulenin (cerulenin used to
induce FAS inhibition). Triglyceride lev-
els were assessed 18 hours later. An-
timycin A approximately doubled triglyc-
erides, a result which was not blocked by
cerulenin. In contrast, cerulenin dramatically
reduced triglyceride levels in nonantimycin
A–exposed cells (P < 0.0001), confirming its
ability to inhibit fatty acid synthesis, and hence
fatty acid flux into triglyceride pools. Right
panel, Antimycin A caused a significant in-
crease in FAS protein, as assessed by Western
blot. Representative blots are depicted (lane
1, antimycin A treatment and lane 2, controls).
Germany). The tissues were homogenized on ice with
approximately forty strokes, and then the samples were
transferred to microcentrifuge tubes. Samples were cen-
trifuged at 14,000 rpm × 15 minutes at 4◦C and the su-
pernatants were saved for lipase activity. The tissue ex-
tracts (200 lL) were incubated × 2 hours at 37◦C with
100 lL of an exogenous triglyceride source (100% canola
oil) (Conagra Foods, Irvine, CA, USA). The FFAs which
were hydrolyzed from the exogenous triglyceride were
measured using the nonesterfied fatty acid colorimetric
(NEFA C) kit following the manufacturer’s instructions
(Wako; Richmond, VA, USA). FFAs were factored by
the total protein present in each homogenate sample
(bichinoninic protein assay method). The results were
expressed as lEq of FFA generated/gram of tissue pro-
tein extract. The validity and linearity of the lipase assay
was confirmed by a dose-titration curve utilizing exoge-
nous pancreatic lipase (Spectrum Chemicals, Gardena,
CA, USA) (0.1 to 25 U/mL) incubated with the canola
oil substrate (generated FFAs vs. added lipase concentra-
tions r = 0.950).
Calculations and statistics
All values are presented as means ± 1 SEM. Statisti-
cal comparisons were made by either unpaired or paired
Student t test. Significance was judged by a P value of
<0.05. If multiple comparisons were made, the Bonfer-
roni correction was applied.
RESULTS
HK-2 cell experiments
Antimycin A–induced triglyceride accumulation: Im-
pact on fatty acid synthesis and FAS expression.
Triglyceride levels. Antimycin A induced an approx-
imate doubling of HK-2 cell triglyceride content (rising
∼60 nmol/lmol Pi over controls) (Fig. 2, left panel). This
antimycin A–induced triglyceride increase was not pre-
vented by the presence of cerulenin (triglyceride rising
∼70 nmol/lmol Pi, compared to cerulenin treated con-
trols) (Fig. 2, left panel, second two columns). Cerulenin’s
ability to suppress FAS in HK-2 cells was confirmed by the
observation that it decreased triglyceride levels by 70%
in nonantimycin A–treated cells (Fig. 2, left panel) (P <
0.0001). In sum, these findings indicate that antimycin A–
induced triglyceride accumulation is not dependent on de
novo fatty acid synthesis.
LDH release. In the above experiments, antimycin A
caused only minimal cell death, as assessed by% LDH
release (control cells 8 ± 1% and antimycin A–treated
cells 12 ± 1%) (P < 0.05). This is consistent with the
fact that glycolysis can maintain ∼70% of normal HK-2
cell ATP levels in the presence of mitochondrial block-
ade [33]. Cerulenin had a slight cytotoxic effect (raising
LDH release from 8 ± 1% to 12 ± 1%) (P < 0.05). How-
ever, when present with antimycin A, cerulenin did not
increase the extent of antimycin A–induced cell death
(12 ± 1%).
Antimycin A effects on HK-2 cell FAS expression. As
shown in Figure 2, right panel, antimycin A treatment ×
18 hours caused an approximate 33% increase in FAS
protein levels, as determined by Western blotting (P <
0.005). Representative blots are depicted (Fig. 2, right
panel, lanes 1 and 2 refer to antimycin A–treated cells
and control cells, respectively).
FATP2 protein and mRNA expression in response to
antimycin A. As shown in Figure 3, left panel, antimycin
A treatment ×18 hours produced an approximate 70%
increase in HK-2 cell FATP2 protein levels, as assessed by
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Fig. 3. Antimycin A (AA) effects on fatty acid transport protein 2
(FATP2) protein/FATP2 mRNA expression in human kidney 2 [HK-2]
cells. Left panel, Antimycin A treatment caused a significant increase
in FATP2 protein, compared to concomitantly incubated control (C)
cells. Representative blots are depicted (lane 1, antimycin A and lane 2,
control extracts). Right panel, Increased FATP2 mRNA was noted after
18 hours (but not 4 hours) of antimycin A incubation. This temporally
corresponded with the increase in FATP2 protein, as noted in the left
panel.
Western blot. Representative blots are depicted by their
respective bars in the graph (lane 1, antimycin A treat-
ment and lane 2, controls). The FATP2 protein increase
corresponded with an approximate doubling of its mRNA
(seen at 18 hours, but not at 4 hours post-antimycin A
treatment) (Fig. 3, right panel).
DGAT1 and DGAT2 mRNA expression: Effects of an-
timycin A. DGAT1 message levels ± antimycin A treat-
ment are depicted in Figure 4, left panel. Antimycin A
caused a statistically significant increase, seen at both 4-
hour and 18-hour time points. As shown in Figure 4, right
panel, DGAT2 mRNA was elevated after 4 hours of an-
timycin A exposure, but with continued (18 hours) an-
timycin A exposure, it returned to control values.
PLA2 effects on HK-2 cell triglyceride levels. As
shown in Figure 5, left panel, incubating HK-2 cells
with either 5 or 20 U/mL of exogenous PLA2 × 3
hours caused dose-dependent increases in cellular triglyc-
eride levels (consistent with PLA2-liberated FFAs being
channeled into triglyceride). The PLA2 additions caused
dose-dependent, but a quantitatively trivial (<2%), in-
crease in cell death, as assessed by% LDH release
(Fig. 5, right panel).
Isolated mouse proximal tubule experiments
FFAs. As shown in Figure 6, left panel, both an-
timycin A and PLA2 treatment significantly raised prox-
imal tubule FFA content (controls 9 nmol/mg protein;
antimycin A 45 nmol/mg; and PLA2 31 nmol/mg, respec-
tively) (P < 0.05). When PLA2 and antimycin A were
applied together, a profound synergistic FFA increase re-
sulted (to ∼250 nmol/mg) (P < 0.01).
Triglycerides. As shown in Figure 6, right panel, PLA2
raised proximal tubular triglyceride content (comparable
to the effects seen with PLA2 treatment of HK-2 cells,
as shown in Fig. 5). Despite the fact that antimycin A
raised FFAs levels, it caused a 50% reduction in tubule
triglyceride content (Fig. 6, right panel). Antimycin A
completely blocked PLA2’s ability to raise tubule triglyc-
eride content.
In vivo mouse experiments: Glycerol-induced ARF
FATP2 protein and mRNA analysis.
Protein. At 18 hours post-induction of glycerol-
mediated ARF, an approximate 80% reduction in FATP2
protein expression was apparent (Fig. 7, left panel, lane
1, controls and lane 2, glycerol treatment). The glycerol-
treated mice had severe rhabdomyolysis-induced ARF,
as evidenced by marked elevations in BUN concentra-
tions (post-glycerol 161 ± 7 mg/dL and controls 28 ± 1
mg/dL) (P < 0.001).
mRNA. By 18 hours post-glycerol, an approximate
60% suppression in FATP2 mRNA was observed (Fig. 7,
right panel). Thus, at the height of the ARF (18 hours
post-glycerol injection), and hence, the height of renal
cortical triglyceride loading [13], marked reductions in
both FATP2 protein and its mRNA were observed.
DGAT1 and DGAT 2 mRNAs post-glycerol injection.
DGAT1 and DGAT2 mRNAs at 18 hours post-glycerol
injection are depicted in Figure 8, left panel. No change
is DGAT1 message was observed. However, there was
an approximate two thirds reduction in DGAT2 mRNA,
a result which corresponds with a three- to fourfold in-
crease in renal cortical triglyceride levels [13].
FAS protein post-glycerol treatment. Mouse kidney
cortex obtained 18 hours post-glycerol injection demon-
strated an approximate 50% reduction in FAS expres-
sion, as analyzed by Western blot (see Fig. 8, right panel).
Representative blots are depicted (lane 1, controls and
lane 2, glycerol treatment samples).
In vivo mouse experiments: Endotoxemic ARF
FATP2 protein and mRNA analyses. As shown in
Figure 9, left panel, by 18 hours post-LPS injection, an ap-
proximate 25% reduction in renal cortical FATP2 protein
was observed (representative blots are depicted) (Fig. 9,
left panel, lane 1, controls and lane 2, LPS treatment).
This was not matched by a reduction in FATP1 mRNA.
Rather a slight, but significant, increase in FATP mRNA
was apparent at 18 hours post-LPS administration (Fig. 9,
right panel). LPS injection severely compromised renal
function, as denoted by 18-hour BUN analysis (controls
29 ± 2 mg/dL vs. 96 ± 4 mg/dL) (P < 0.0001).
DGAT1 and DAGT2 mRNA levels after LPS-induced
ARF. As shown in Figure 10, left panel, DGAT1 and
DGAT2 mRNAs were increased by ∼65% and ∼45%,
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Fig. 4. Acyl-coenzyme A:diacylglycerol
acyltransferases DGAT1 and DGAT2
mRNA responses to antimycin A–mediated
human kidney 2 (HK-2) cell injury. Left
panel, Antimycin A induced significant
elevations in DGAT1 mRNA levels after
both 4-hour and 18-hour incubations. Right
panel, DGAT2 mRNA levels were also
increased by antimycin A exposure, but
the effect was transient, with a significant
difference being observed after 4, but not 18
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Fig. 5. Exogenous phospholipase A2
(PLA2) effects on human kidney 2 (HK-2)
cell triglyceride (TG) content. Left panel,
Pancreatic PLA2 addition to HK-2 cells
caused a dose dependent increase in triglyc-
eride content. Right panel, This PLA2 effect
occurred despite minimal lethal cell injury, as
assessed by% lactate dehydrogenase (LDH)
release (increases of ≤2% even at the 20
U/mL dosage).
respectively, by 18 hours post-LPS treatment. This cor-
responded to a previously observed three- to fourfold
increase in triglyceride levels at this time point [13].
FAS protein expression following endotoxemia. FAS
protein levels appeared to be unaffected by the endotox-
emic state, as assessed by Western blot analysis. Values
and representative blots are presented in Figure 10, right
panel (control, lane 1 and LPS treatment, lane 2).
Tissue lipase activity with the in vitro and in vivo
injury protocols
Both the post-glycerol and post-ischemic renal cortical
tissues had significant depressions in tissue lipase activity
(Fig. 11). Conversely, in the case of endotoxemia, a signif-
icant increase in lipase activity was discerned [Note: pilot
data indicated that differences in tissue lipase did not re-
sult from differences in plasma lipase levels, with possible
contamination of tissue samples, as plasma lipase levels
were assayed with a commercially available kit (#805B)
(Trinity Biotech; Jamestown, NY) and values were highly
comparable for the controls vs. the experimental groups].
DISCUSSION
In a previous study [13], we demonstrated that in-
creased extracellular fatty acid uptake, with subsequent
conversion into triglyceride, is one mechanism by which
cell injury can evoke a triglyceride loading state. This
statement was based on the observation that when fatty
acids were added to antimycin A–challenged HK-2 cells,
exaggerated triglyceride formation resulted. One poten-
tial mediator of increased fatty acid uptake, with subse-
quent triglyceride formation, would be an injury-induced
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Fig. 6. Antimycin A (AA) effects on mouse
isolated proximal tubule free fatty acid (FFA)
and triglyceride (TG) content. Left panel,
Both antimycin A and exogenous phospho-
lipase A2 (PLA2) addition to isolated mouse
proximal tubules caused modest increases in
FFA content (∗P < 0.05). When antimycin
A and PLA2 were added together, a strik-
ing synergistic increase in FFA accumulation
resulted. Right panel, Despite the fact that
antimycin A could increase FFA (i.e., triglyc-
eride substrate) content, when added by
itself to proximal tubules, antimycin A sup-
pressed triglyceride levels by ∼50%. Con-
versely, PLA2 addition to isolated tubules
caused an approximate doubling of triglyc-
eride content. However, this PLA2-induced
triglyceride increase was completely blocked
by concomitant antimycin A treatment. Thus,
these results are consistent with the concepts
that (1) mitochondrial inhibition raises FFA
levels (due to decreased mitochondrial con-
sumption ± endogenous PLA2 activation);
and (2) if adenosine triphosphate (ATP) de-
pletion results (as is the case with antimycin
A treatment of isolated tubules), the liber-
ated FFAs cannot be incorporated into cel-
lular triglyceride pools (presumably because
of a failure of fatty acid activation).
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Fig. 7. Glycerol-induced acute renal failure
(ARF): Effects on fatty acid transport protein
2 (FATP2) protein/mRNA expression. Left
panel, By 18 hours post-glycerol (glyc) injec-
tion, an approximate 80% reduction in FATP2
protein levels was observed, compared to val-
ues observed in control (C) kidneys. Repre-
sentative blots (lane 1, controls and lane 2,
glycerol treatment) are depicted. Right panel,
The reduction in FATP2 protein was accom-
panied by a comparable decrement in FATP2
mRNA, suggesting that FATP2 reductions
may have been, in part, due to decreased gene
transcription/message translation.
increase in FATP2, the dominant renal tubular plasma
membrane fatty acid transporter [25, 26]. The present
study provides direct support for this hypothesis. When
antimycin A–treated HK-2 cells were probed for FATP2,
an approximate twofold increase was noted by Western
blot. A comparable increase in FATP2 mRNA accom-
panied the protein increase, suggesting that increased
transcription was at least partially responsible. To our
knowledge, this is the first demonstration that FATP2,
and its message, can be induced by an acute tubular cell
injury state.
While our findings indicate that antimycin A–induced
injury can increase FATP2 levels, potentially increasing
fatty acid uptake [13], the present HK-2 cell studies also il-
lustrate that HK-2 cells can accumulate triglyceride inde-
pendently of FATP2-mediated fatty acid transport. This
conclusion is based on the fact that the employed HK-
2 cell culture medium (K-SFM) has no free fatty acid
content (confirmed by medium fatty acid assay, both be-
fore and after the antimycin A challenge; pilot data).
The absence of exogenous fatty acid precludes increased
extracellular fatty acid uptake; nevertheless, antimycin
A still doubled HK-2 cell triglyceride content (Fig. 2).
Thus, alternative mechanisms for triglyceride accumu-
lation must exist. This led us to explore the possibility
that injury might increase FAS, providing de novo fatty
acid for DGAT-mediated triglyceride formation. West-
ern blot analysis confirmed that antimycin A treatment
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Fig. 8. Glycerol-induced acute renal fail-
ure (ARF): Effects on acyl-coenzyme
A:diacylglycerol acyltransferase DGAT
mRNAs and fatty acid synthase (FAS)
expression. Left panel, DGAT1 and DGAT2
mRNAs were assessed 18 hours post-glycerol
(glyc) injection. DGAT1 message remained
unchanged. However, an approximate 50%
reduction in DGAT2 mRNA was observed.
Right panel, FAS expression was reduced
by ∼50% following glycerol injection, sug-
gesting that de novo fatty acid synthesis is an
unlikely explanation for the glycerol-induced
triglyceride increments [13].
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Fig. 9. Lipopolysaccharide (LPS)-induced
acute renal failure (ARF): Effects on
fatty acid transport protein 2 (FATP2)
protein/mRNA expression. Left panel, LPS
caused a modest, but significant, reduction
in FATP2 protein levels. Right panel, FATP2
mRNA values were increased, rather than
suppressed, at the time of the FATP2 protein
reduction.
can, indeed, increase FAS levels. This suggested that de
novo fatty acid synthesis might be critical to antimycin
A–mediated triglyceride accumulation. However, the re-
sults obtained with cerulenin rule out this hypothesis,
given that this FAS inhibitor did not prevent triglyceride
loading during antimycin A–induced HK-2 cell attack.
Of note, cerulenin lowered HK-2 cell triglyceride levels
by ∼75% in the absence of antimycin A. This confirmed
its ability to inhibit HK-2 cell FAS. Thus, the data de-
rived from the above two sets of experiments indicate
that although increased FATP2-mediated fatty acid trans-
port and increased FAS expression might each contribute
to antimycin A–mediated triglyceride loading, additional
mechanisms for the triglyceride pool enhancement must
exist.
Given the above, we tested a third hypothesis: that
antimycin A, which is known to activate PLA2 in cul-
tured tubular cells, releasing FFAs from phospholipids
[27], might allow for DGAT-mediated fatty acid flux into
triglyceride pools. To test this hypothesis, HK-2 cells were
incubated with exogenous PLA2, followed by triglyc-
eride assessment. Indeed, PLA2 induced dose-dependent
triglyceride formation, directly supporting the above hy-
pothesis. To ascertain whether antimycin A might also
stimulate DGAT expression, DGAT1 and DGAT2 mR-
NAs were assessed, and increases in both were observed.
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Fig. 10. Lipopolysaccharide (LPS)-induced
acute renal failure (ARF): Effects on acyl-
coenzyme A:diacylglycerol acyltransferase
DGAT message and fatty acid synthase (FAS)
expression. Left panel, Renal cortical DGAT1
and DGAT2 mRNAs were assessed 18 hours
post-LPS injection. At the 18-hour time point,
both message levels were significantly in-
creased, compared to controls. Right panel,
No significant change in FAS levels were ap-
parent in post-LPS treated kidneys, as as-
sessed by Western blotting (lane 1, control and
lane 2, post-LPS).
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Fig. 11. Tissue lipase activity 18 hours post in vivo renal injury pro-
tocols. Glycerol-induced renal injury (Glyc), and ischemic/reperfusion
(I/R) injury each caused signficant reductions in renal cortical lipase
activity (∼20% and ∼35%, respectively), compared to their controls
(C). Conversely, by 18 hours post-LPS injection, a significant increase
in renal cortical lipase levels was apparent.
We were unable to ascertain whether these mRNA in-
crements up-regulate DGAT protein, due to a lack of
available antibodies for Western blotting. Nevertheless,
the mRNA results do suggest that antimycin A provides
the appropriate stimulus for such a result.
A number of theoretic links exist between mitochon-
drial respiration, FFA availability, and triglyceride for-
mation. Given that the mitochondrion utilizes fatty acids
for ATP production via beta oxidation, decreased mito-
chondrial respiration would be expected to decrease fatty
acid consumption, potentially increasing FFA availabil-
ity for triglyceride synthesis. Conversely, if severe ATP
depletion results, ATP dependent “activation” of accu-
mulating fatty acids (via acyl-coenzyme A formation)
might cease, possibly preventing FFA incorporation into
triglyceride pools (see Fig. 1). To evaluate these possi-
bilities, the impact of mitochondrial blockade on FFA
levels and triglyceride formation was assessed. Freshly
isolated mouse proximal tubules were used for this
purpose, given that they (unlike HK-2 cells) [33] are
completely dependent on aerobic ATP production. An-
timycin A markedly increased proximal tubule FFA
levels, particularly, when exogenous PLA2 was present
(Fig. 5). This is consistent with the concept that mitochon-
drial blockade can decrease FFA consumption, poten-
tially raising FFA pools. Also noteworthy was the finding
that antimycin A–induced mitochondrial blockade inhib-
ited proximal tubule triglyceride formation, despite the
FFA increases. For example, whereas PLA2 treatment
doubled tubule triglyceride levels in the absence of an-
timycin A, PLA2 failed to increase triglycerides when
antimycin A was present. Furthermore, antimycin A
decreased, rather than increased, triglyceride levels in
non-PLA2-exposed tubules. These results underscore
two relevant points. First, decreased mitochondrial res-
piration can increase FFA levels. Second, despite this re-
sult, if profound ATP depletion results, the accumulated
FFAs cannot be converted into cellular triglyceride pools
(presumably due to lack of ATP-dependent fatty acid
activation). Given these findings, it seems clear that no
simple, direct relationship exists between mitochondrial
respiration, FFA increments, and corresponding triglyc-
eride levels. Of note, when antimycin A is added to HK-2
cells, mitochondrial blockade, but only mild ATP reduc-
tions, develops (due to continued anaerobic ATP produc-
tion) [33]. Thus, under these circumstances, mitochon-
drial blockade, with decreased mitochondrial fatty acid
consumption, might well enhance triglyceride pools.
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Table 3. Summary of results and comparisons of injury models
FATP2 (protein) FATP2 (mRNA) FAS (protein) DGAT1 (mRNA) DGAT2 (mRNA) Lipase
HK-2: AA ↑ ↑ ↑ ↑ ↑ ND
Glycerol ↓ ↓ ↓ NS ↓ ↓
Endotoxin ↓ ↑ NS ↑ ↑ ↑
Abbreviations are: FATP2, fatty acid transport protein 2; FAS, fatty acid synthase; DGAT, acyl-coenzyme A:diacylglycerol acyltransferase; HK-2 human kidney 2;
AA, antimycin A, NS, no significant change; ND, not done.
The directional results for the assessments which were made are presented. Lipase activity could not be accurately assessed in the HK-2 cell experiments due to
insufficient assay sensitivity. Thus, in addition to assessing lipase activity in the glycerol and endotoxemic model, a third in vivo model, in vivo ischemia/reperfusion,
was undertaken and the results are presented in Figure 11.
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Fig. 12. (A) Proposed pathways of triglyceride (TG) accumulation in
human kidney 2 (HK-2) cells with antimycin A. The data gathered sug-
gest that essentially all of the proposed pathways in cellular triglyceride
homeostasis are perturbed during antimycin A–mediated HK-2 cell
injury, each favoring increased triglyceride levels. These include (1) up-
regulation of fatty acid transport protein 2 (FATP2) expression (protein
and mRNA), augmenting fatty acid uptake (assuming the presence of
extracellular fatty acids); (2) increased phospholipase A2 (PLA2) ac-
tivity [27] would also lead to increased triglyceride formation [via fatty
acid mobilization from phospholipids (PL)]; (3) increased fatty acid
(FA) synthase (FAS), which could contribute to triglyceride formation;
(4) antimycin A–induced mitochondrial blockade, decreasing fatty acid
consumption (thereby increasing fatty acid pools); and (5) increased
acyl-coenzyme A:diacylglycerol acyltransferases DGAT mRNA
In addition to increased triglyceride formation, im-
pacted by the multiple factors discussed above, decreased
triglyceride hydrolysis could also contribute to a triglyc-
eride loading state. We were unable to ascertain the im-
pact of antimycin A on HK-2 cell lipase levels, due to a
relative lack of sensitivity of the developed assay. How-
ever, to gain insights into this issue, tissue lipase activ-
ity was assessed following three forms of in vivo injury:
I/R, glycerol induced rhabdomyolysis, and endotoxemic
ARF. Noteworthy were the findings that both I/R and
glycerol-induced rhabdomyolysis caused 20% to 35% re-
ductions in renal cortical lipase activity. Thus, increased
triglyceride synthesis may not be the sole explanation for
a post-injury triglyceride loading state. However, it is also
noteworthy that in the case of endotoxemia, increased,
not decreased, lipase activity resulted. The reason for this
striking difference in lipase activity amongst these three
in vivo injury models remains unknown. However, given
the marked differences between endotoxemia, a hemo-
dynamic form of ARF, vs. I/R or glycerol-induced acute
tubular necrosis, differences in lipase activity should not
be unexpected. These differences underscore that triglyc-
eride accumulation in post-injured tissues can arise from
multiple, complex, and likely disease-specific perturba-
tions in triglyceride homeostatic pathways.
To further contrast mechanisms for injury-evoked
triglyceride accumulation, triglyceride synthetic path-
ways during the glycerol and endotoxemic models of
expression, presumably increasing DGAT enzyme expression/activity,
and hence, triglyceride synthesis (lipase activity in antimycin A–
challenged HK-2 cells could not be ascertained). (B) Potential path-
ways involved with triglyceride homeostasis with in vivo renal injury.
The solid and dashed arrows represent the glycerol and the lipopolysac-
charide (LPS) models of acute renal failure (ARF), respectively. ↑,
↓, and ← → represent increased, decreased, or unchanged activities,
respectively. Unlike, the HK-2 model, FATP2 protein expression was
suppressed by both glycerol and LPS-mediated renal injury. This obser-
vation, plus the fact that FAS failed to increase with either in vivo injury
model, suggest that PLA2 activation/PL degradation (known to occur
with both forms of injury), coupled with decreased mitochondrial fatty
acid consumption [dictated either by mitochondrial injury or a decrease
in glomerular filtration rate (GFR)], are the dominant factors providing
excess fatty acid for triglyceride synthesis. The latter can occur whether
or not DGAT mRNA levels are increased. Finally, tissue lipase activity
is an additional arbitor of triglyceride levels in these two injury models,
given that it can either fall (glycerol) or rise (LPS) with in vivo renal
damage.
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ARF were assessed. The results obtained were then con-
trasted both between these two injury models, and with
the previously obtained in vitro HK-2 cell results. In-
deed, striking differences among these injury models
were observed, which are outlined in Table 3. Most no-
table were the following: (1) in contrast to heightened
FATP2 expression in antimycin A–challenged HK-2 cells,
FATP2 protein levels were markedly suppressed with
in vivo ARF (particularly following rhabdomyolysis);
(2) whereas FAS was elevated following antimycin A–
induced HK-2 cell injury, it was either suppressed (glyc-
erol) or unchanged (LPS) following in vivo ARF; and (3)
antimycin A augmented HK-2 cell DGAT mRNAs; con-
versely, DGAT messages were either increased (LPS), or
decreased (glycerol) following in vivo ARF. These differ-
ences, once again, underscore that multiple and disease
specific pathways likely contribute to a post-injury triglyc-
eride loading state. Based on the information gathered
above, the dominant pathways thought to contribute to
triglyceride accumulation in each of the models studied
are presented schematically in Figure 12.
CONCLUSION
The present experiments have evaluated potential
mechanisms of cellular triglyceride accumulation fol-
lowing highly divergent in vivo and in vitro models of
tubular cell damage. The data obtained underscore the
complexity of this process, which may involve alterations
in triglyceride synthesis (DGAT expression), fatty acid
(triglyceride substrate) availability (FATP2, FAS, PLA2
activity, and mitochondrial FFA consumption), and
triglyceride degradative (lipase) pathways. The degrees
to which each of these may participate in injury-induced
triglyceride accumulation appear to vary greatly, depend-
ing on the types of tissue injury sustained. Thus, the
concept that injury-induced triglyceride accumulation
simply stems from a flux of excess fatty acid into triglyc-
eride pools would seem to underestimate the complexity
of the issues at hand. That triglyceride accumulation ex-
presses itself despite divergent underlying mechanisms
would seem to underscore the importance of this process
to cellular homeostasis in the aftermath of diverse forms
tubular cell attack.
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